Pharmaceuticals South Africa

South Africa Exosome Therapeutics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

South Africa Exosome Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Application, Source, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

South Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.5 Mn Placeholder estimate
Estimate 2025 $1.9 Mn 0.6% of the global market
Projected 2034 $16.1 Mn 735.4% Adds $14.1 Mn over 9 forecast years
CAGR 2025–2034 26.6% Faster than 95% of 183 Pharmaceuticals markets here
Key players 5 Companies profiled
  • South Africa is 0.62% of the global market.
  • In Africa, the largest is South Africa (this report) at $1.9 Mn.
  • Fastest growing: South Africa (this report) at 26.6% a year.
  • South Africa ranks 1st of 3 by size in Africa.

Market size projection

South Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$14.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Exosome Therapeutics Market market size by year, South Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.5 Mn — —
2025 (base) $1.9 Mn +$0.4 Mn —
2026 (forecast) $2.4 Mn +$0.5 Mn +26.6%
2027 (forecast) $3.1 Mn +$0.6 Mn +60.3%
2028 (forecast) $3.9 Mn +$0.8 Mn +102.9%
2029 (forecast) $4.9 Mn +$1.0 Mn +156.9%
2030 (forecast) $6.3 Mn +$1.3 Mn +225.2%
2031 (forecast) $7.9 Mn +$1.7 Mn +311.7%
2032 (forecast) $10.0 Mn +$2.1 Mn +421.2%
2033 (forecast) $12.7 Mn +$2.7 Mn +559.9%
2034 (forecast) $16.1 Mn +$3.4 Mn +735.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

South Africa Exosome Therapeutics Market Analysis at a glance
Market size, 2025$1.9 Mn placeholder estimate
Forecast, 2034$16.1 Mn placeholder estimate
Growth (CAGR), 2025–203426.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, source and end user (see all)
Key playersCodiak BioSciences, Evox Therapeutics, Aegle Therapeutics, Capricor Therapeutics, ExoCoBio, Inc (see all)
Regulator in South AfricaSAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The South Africa Exosome Therapeutics Market Analysis Executive Summary

Exosome therapeutics use tiny vesicles released by cells to carry drugs or healing signals, for cancer, inflammation and regenerative medicine.

Key segments of the exosome Therapeutics market include application (Drug Delivery, Regenerative Medicine and Diagnostics) and source (Stem Cell-Derived, Plant-Derived and Engineered).

Bar chart: South Africa Exosome Therapeutics market size, 2024–2034, placeholder estimates. $1.5 Mn in 2024, $1.9 Mn in 2025 and $16.1 Mn in 2034, 26.6% CAGR.
South Africa Exosome Therapeutics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

South Africa Exosome Therapeutics Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the exosome Therapeutics market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the exosome Therapeutics market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the exosome Therapeutics market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Exosome Therapeutics Market in South Africa

The exosome Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Exosome Therapeutics Market in South Africa

Exosome Therapeutics in South Africa: rules and payment

The South African Health Products Regulatory Authority (SAHPRA) registers medicines.⁠[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.⁠[2]

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for exosome Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Exosome Therapeutics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Exosome Therapeutics in context

South Africa compared

  • Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 6.9% of people (2025). World: 10.4% of people (2025). 2nd highest of the 17 countries we cover in Africa.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Exosome Therapeutics market in South Africa?
Placeholder estimate: about $1.9 Mn in 2025, rising to about $16.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Exosome Therapeutics market in South Africa growing?
Placeholder estimate: about 26.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Exosome Therapeutics market report cover?
The report splits the market by application (Drug Delivery, Regenerative Medicine, Diagnostics, Oncology), source (Stem Cell-Derived, Plant-Derived, Engineered) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Exosome Therapeutics market?
Key players include Codiak BioSciences, Evox Therapeutics, Aegle Therapeutics, Capricor Therapeutics and ExoCoBio, Inc.
What is driving the Exosome Therapeutics market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the exosome Therapeutics market.
Who regulates Exosome Therapeutics in South Africa?
The South African Health Products Regulatory Authority (SAHPRA) registers medicines. Source: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
How is healthcare paid for in South Africa?
Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone. Source: National Department of Health. Checked 14 Nov 2026.
How much research is published on Exosome Therapeutics?
PubMed lists 29 papers on Exosome Therapeutics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in South Africa

See all

Related on biologics and biosimilars and genomics

See the topic